Trial Information

Summary: Osteoporosis Study for Men.

Osteoporosis in men represents an important, although long underestimated public health problem. At least 20 percent of cases of osteoporosis occur in men and may lead to bone fractures and height loss.

Diablo Clinical Research and Dr. Richard Weinstein are conducting a research study to compare the effectiveness of 2 treatments: a yearly infusion of zoledronic acid (Zometa®) versus a weekly oral dose of alendronate (Fosamax®).

You may qualify for the study if you:

  • are a male aged 25 - 85
  • have been diagnosed with osteoporosis

Qualified participants receive at no cost:

  • All investigational medications
  • Study-related physical examinations
  • Bone density testing & X-rays
  • Laboratory tests

To learn more,

Contact:

Ava Paulazzo, Marketing & Community Outreach
Diablo Clinical Research
2255 Ygnacio Valley Road, Ste. M
Walnut Creek, CA 94598
Telephone: 925-930-7267
Fax: 925-930-7392
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:03 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA